| Authors: |
Lynch DS; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK david.lynch.13@ucl.ac.uk.; National Hospital for Neurology and Neurosurgery, London, UK., Wade C; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK., Carlson AK; Department of Neurology, Mellen Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA., Barkhof F; Department of Neuroinflammation, UCL Institute of Neurology, London, UK.; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Amsterdam, The Netherlands., Yoshida T; Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Neurology, Japan Community Healthcare Organization Kobe Central Hospital, Kobe, Japan., Collins A; Ionis, Carlsbad, California, USA., Edwards MR; Ionis, Carlsbad, California, USA., Waldman AT; Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Departments of Neurology and Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. |